HealthEquity Company Insiders

HQY Stock  USD 94.38  2.53  2.61%   
HealthEquity employs about 3.1 K people. The company is managed by 20 executives with a total tenure of roughly 72 years, averaging almost 3.0 years of service per executive, having 155.25 employees per reported executive. Break down of HealthEquity's management performance can provide insight into the company performance.
Jon Kessler  CEO
CEO and President and Director
Stephen Neeleman  Chairman
Vice Chairman of the Board, Founder
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.

HealthEquity Management Team Effectiveness

The company has Return on Asset of 0.0457 % which means that on every $100 spent on assets, it made $0.0457 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0577 %, implying that it generated $0.0577 on every 100 dollars invested. HealthEquity's management efficiency ratios could be used to measure how well HealthEquity manages its routine affairs as well as how well it operates its assets and liabilities.

HealthEquity Workforce Comparison

HealthEquity is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 31,726. HealthEquity holds roughly 3,105 in number of employees claiming about 10% of equities under Health Care industry.
The company has Net Profit Margin of 0.1 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.26 %, which entails that for every 100 dollars of revenue, it generated $0.26 of operating income.

HealthEquity Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific HealthEquity insiders, such as employees or executives, is commonly permitted as long as it does not rely on HealthEquity's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, HealthEquity insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

HealthEquity Notable Stakeholders

A HealthEquity stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as HealthEquity often face trade-offs trying to please all of them. HealthEquity's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting HealthEquity's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Jon KesslerCEO and President and DirectorProfile
Scott JDPresident CEOProfile
Stephen MDFounder ChairmanProfile
Stephen NeelemanVice Chairman of the Board, FounderProfile
Larry TrittschuhExecutive Vice President Chief Security OfficerProfile
Angelique HillExecutive Vice President - OperationsProfile
Delano LaddExecutive Vice President General Counsel and Corporate SecretaryProfile
James LucaniaCFO VPProfile
Darcy MottCFO, Executive VP and TreasurerProfile
Elimelech RosnerExecutive CTOProfile
Delano JDGeneral VPProfile
Cheryl KingExecutive OfficerProfile
Tia PadiaExecutive OfficerProfile
Richard PutnamIR Contact OfficerProfile
Jeff VenutiNew ConsultantProfile
Brad BennionSenior DevelopmentProfile
Tyson MurdockEx CFOProfile
Steve LindsayExecutive ManagementProfile
Kamesh TumsiSenior ProductProfile
Michael FioreExecutive OfficerProfile

About HealthEquity Management Performance

The success or failure of an entity such as HealthEquity often depends on how effective the management is. HealthEquity management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of HealthEquity management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the HealthEquity management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company was incorporated in 2002 and is headquartered in Draper, Utah. Healthequity operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3688 people.
Please note, the imprecision that can be found in HealthEquity's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of HealthEquity. Check HealthEquity's Beneish M Score to see the likelihood of HealthEquity's management manipulating its earnings.

HealthEquity Workforce Analysis

Traditionally, organizations such as HealthEquity use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare HealthEquity within its industry.

HealthEquity Manpower Efficiency

Return on HealthEquity Manpower

Revenue Per Employee386.4K
Revenue Per Executive60M
Net Income Per Employee31.1K
Net Income Per Executive4.8M
Working Capital Per Employee103.5K
Working Capital Per Executive16.1M

Additional Tools for HealthEquity Stock Analysis

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.